BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12911040)

  • 1. Allogeneic stem cell transplantation for chronic myeloproliferative disorders and myelodysplastic syndromes: the question is "when?".
    Maziarz RT; Mesa RA; Tefferi A
    Mayo Clin Proc; 2003 Aug; 78(8):941-3. PubMed ID: 12911040
    [No Abstract]   [Full Text] [Related]  

  • 2. Hematopoietic cell transplantation for adult patients with myelodysplastic syndromes and myeloproliferative disorders.
    Benesch M; Deeg HJ
    Mayo Clin Proc; 2003 Aug; 78(8):981-90. PubMed ID: 12911046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focus on myeloproliferative diseases and myelodysplastic syndromes.
    Van Etten RA; Shannon KM
    Cancer Cell; 2004 Dec; 6(6):547-52. PubMed ID: 15607959
    [No Abstract]   [Full Text] [Related]  

  • 4. Allogeneic hematopoietic stem cell transplantation for myeloproliferative disorders and myelodysplastic syndromes.
    Wayne AS; Barrett AJ
    Hematol Oncol Clin North Am; 2003 Oct; 17(5):1243-60. PubMed ID: 14560785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic transplantation of haematopoietic progenitors for myelodysplastic syndromes and myeloproliferative disorders.
    Locatelli F; Giorgiani G; Comoli P
    Bone Marrow Transplant; 1998 Apr; 21 Suppl 2():S17-20. PubMed ID: 9630318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The myelodysplastic syndromes and myeloproliferative disorders.
    Williams JL
    Clin Lab Sci; 2004; 17(4):223-34. PubMed ID: 15559729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Stem cells in hematology and oncology].
    Goldschmidt H; Egerer G; Fruehauf S; Ho AD
    Med Klin (Munich); 2003 Dec; 98 Suppl 2():11-4. PubMed ID: 14992195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myelodysplastic and myeloproliferative disorders in children.
    Hasle H
    Curr Opin Pediatr; 2007 Feb; 19(1):1-8. PubMed ID: 17224655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mixed chimerism: good news or bad news?
    Parkman R
    Biol Blood Marrow Transplant; 2014 Jun; 20(6):750-1. PubMed ID: 24732782
    [No Abstract]   [Full Text] [Related]  

  • 11. Allogeneic bone marrow transplantation and donor lymphocyte infusion in a mouse model of irradiation-induced myelodysplastic/myeloproliferation syndrome (MD/MPS): evidence for a graft-versus-MD/MPS effect.
    Sprangers B; Van Wijmeersch B; Luyckx A; Sagaert X; De Somer L; Rutgeerts O; Lenaerts C; Landuyt W; Boeckx N; Dubois B; De Wolf-Peeters C; Waer M; Billiau AD
    Leukemia; 2009 Feb; 23(2):340-9. PubMed ID: 18987665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes and acute myelogenous leukemia.
    Valcárcel D; Martino R
    Curr Opin Oncol; 2007 Nov; 19(6):660-6. PubMed ID: 17906468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topics in pediatric leukemia--myelodysplastic and myeloproliferative disorders of childhood.
    Lasky J; Sakamoto KM
    MedGenMed; 2005 Mar; 7(1):21. PubMed ID: 16369326
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem-cell transplantation.
    Platzbecker U; Ehninger G; Bornhäuser M
    Blood; 2007 Oct; 110(8):3083; author reply 3083-4. PubMed ID: 17916753
    [No Abstract]   [Full Text] [Related]  

  • 15. Does T-cell depletion have a future in allogeneic stem cell transplantation?
    de Witte TM
    Leuk Res; 2008 Sep; 32(9):1354-5. PubMed ID: 18346785
    [No Abstract]   [Full Text] [Related]  

  • 16. Second allogeneic stem cell transplantation in a patient with hypoplastic myelodysplastic syndrome following a primary diagnosis of aplastic anaemia.
    Ocheni S; Oyekunle A; Kröger N; Ayuk F; Klyuchnikov E; Arps S; Held K; Zabelina T; Adjallé R; Wolschke C; Zander AR; Bacher U
    Acta Haematol; 2011; 125(3):175-8. PubMed ID: 21196720
    [No Abstract]   [Full Text] [Related]  

  • 17. Optimizing management of myelodysplastic syndromes post-allogeneic transplantation.
    Sockel K; Ehninger G; Hofbauer LC; Platzbecker U
    Expert Rev Hematol; 2011 Dec; 4(6):669-80. PubMed ID: 22077530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of allogeneic-cell transplantation in leukemia.
    Kersey JH
    N Engl J Med; 2010 Nov; 363(22):2158-9. PubMed ID: 21105798
    [No Abstract]   [Full Text] [Related]  

  • 19. Allogeneic and autologous stem cell transplantation in myelodysplastic syndromes.
    De Witte T
    Pathol Biol (Paris); 1997 Oct; 45(8):643-9. PubMed ID: 9569930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Granulocyte transfusion for the treatment of prolonged pneumonia in a patient with MDS-RAEB-2 at allogeneic hematopoietic stem cell transplantation].
    Morita R; Hashino S; Takahashi S; Kanamori H; Onozawa M; Kahata K; Kondo T; Imamura M; Asaka M
    Rinsho Ketsueki; 2008 Feb; 49(2):89-93. PubMed ID: 18341038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.